This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.48% per year. These returns cover a period from January 1, 1988 through May 5, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
zacks-consensus-estimate: Archive
Surging Earnings Estimates Signal Upside for European Wax Center (EWCZ) Stock
by Zacks Equity Research
European Wax Center (EWCZ) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
EWCZNegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Surging Earnings Estimates Signal Upside for Dynatrace (DT) Stock
by Zacks Equity Research
Dynatrace (DT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
DTPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Surging Earnings Estimates Signal Upside for Alerus (ALRS) Stock
by Zacks Equity Research
Alerus (ALRS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
ALRSPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Earnings Estimates Moving Higher for Brainsway (BWAY): Time to Buy?
by Zacks Equity Research
Brainsway (BWAY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
BWAYNegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Instil Bio (TIL) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Instil Bio (TIL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
TILPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Freightos Limited (CRGO) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Freightos Limited (CRGO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
CRGONegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
What Makes Ares Commercial Real Estate (ACRE) a New Strong Buy Stock
by Zacks Equity Research
Ares Commercial Real Estate (ACRE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
ACREPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Werewolf Therapeutics (HOWL) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Werewolf Therapeutics (HOWL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
HOWLPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Wolters Kluwer (WTKWY) Upgraded to Strong Buy: Here's Why
by Zacks Equity Research
Wolters Kluwer (WTKWY) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
WTKWYNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Pacific Biosciences (PACB) Rating Upgrade to Buy
by Zacks Equity Research
Pacific Biosciences (PACB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
PACBNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Eastern Bankshares (EBC) Rating Upgrade to Strong Buy
by Zacks Equity Research
Eastern Bankshares (EBC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
EBCPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Globale Online (GLBE) Rating Upgrade to Buy
by Zacks Equity Research
Globale Online (GLBE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
GLBEPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Midland States Bancorp (MSBI) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Midland States Bancorp (MSBI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
MSBIPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Clearside Biomedical (CLSD) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Clearside Biomedical (CLSD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
CLSDNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
W.P. Carey (WPC) Up 0.6% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
W.P. Carey (WPC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
WPCPositive Net Change DLRPositive Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Xylem (XYL) Up 4.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Xylem (XYL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
XYLNegative Net Change PNRPositive Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Zebra (ZBRA) Up 16.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Zebra (ZBRA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
ZBRAPositive Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
TriMas (TRS) Up 10.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
TriMas (TRS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
TRSPositive Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
UMB (UMBF) Up 9.5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
UMB (UMBF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
UMBFPositive Net Change ASBPositive Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Unum (UNM) Up 3.8% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Unum (UNM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
UNMPositive Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Visa (V) Up 4.1% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Visa (V) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
VPositive Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Why Is Werner (WERN) Up 6% Since Last Earnings Report?
by Zacks Equity Research
Werner (WERN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
WERNPositive Net Change JBHTPositive Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Snap (SNAP) Up 4.8% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Snap (SNAP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
SNAPNegative Net Change FFIVNegative Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Why Is SoFi Technologies (SOFI) Up 6.5% Since Last Earnings Report?
by Zacks Equity Research
SoFi Technologies (SOFI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
SOFINegative Net Change BXNegative Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Why Is S&P Global (SPGI) Up 2.3% Since Last Earnings Report?
by Zacks Equity Research
S&P Global (SPGI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
SPGIPositive Net Change TRUNegative Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate